F Dx Advisors, Inc. Gsk PLC Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$42.05 - $47.77 $112,988 - $128,357	2,687 Added 17.67%	17,892 $779,000
Q1 2022 May 03, 2022	BUY	$40.23 - $47.74 $611,697 - $725,886	15,205 New	15,205 $662,000
Q4 2021 Feb 01, 2022	SELL	$38.88 - $45.31 $366,677 - $427,318	-9,431 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$36.52 - $41.46 $213,167 - $242,002	-5,837 Reduced 38.23%	9,431 $376,000
Q1 2021 Apr 14, 2021	BUY	$34.27 - $40.01 $504,557 - $589,067	14,723 Added 2701.47%	15,268 $545,000
Q1 2021 Apr 13, 2021	SELL	$34.27 - $40.01 $384,303 - $448,672	-11,214 Reduced 95.37%	545 $19,000
Q4 2020 Feb 08, 2021	SELL	$34.07 - $39.94 $465,702 - $545,939	-13,669 Reduced 53.76%	11,759 $433,000
Q3 2020 Nov 12, 2020	SELL	$38.11 - $42.99 $637,580 - $719,222	-16,730 Reduced 39.68%	25,428 $957,000
Q2 2020 Jul 22, 2020	BUY	$37.87 - $43.58 $304,664 - $350,601	8,045 Added 23.58%	42,158 $1.72 Million
Q1 2020 May 22, 2020	BUY	$32.47 - $48.83 $90,753 - $136,479	2,795 Added 8.92%	34,113 $1.29 Million
Q1 2020 May 13, 2020	SELL	$32.47 - $48.83 $159,849 - $240,390	-4,923 Reduced 13.58%	31,318 $252,000
Q4 2019 Feb 12, 2020	SELL	$42.0 - $48.25 $50,820 - $58,382	-1,210 Reduced 3.23%	36,241 $1.7 Million
Q3 2019 Nov 07, 2019	SELL	$40.46 - $43.52 $1.28 Million - $1.37 Million	-31,549 Reduced 45.72%	37,451 $1.6 Million
Q2 2019 Jul 19, 2019	SELL	$39.4 - $42.7 $191,090 - $207,095	-4,850 Reduced 6.57%	69,000 $2.76 Million
Q1 2019 May 14, 2019	BUY	$38.57 - $42.69 $1.16 Million - $1.28 Million	30,000 Added 68.42%	73,850 $3.09 Million
Q4 2018 Apr 29, 2019	SELL	$37.8 - $42.69 $1.39 Million - $1.57 Million	-36,746 Reduced 45.59%	43,850 $1.68 Million
Q4 2018 Feb 07, 2019	BUY	$37.8 - $42.69 $274,692 - $310,228	7,267 Added 9.91%	80,596 $3.08 Million
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $184,678 - $198,337	-4,646 Reduced 5.96%	73,329 $2.95 Million
Q2 2018 Aug 08, 2018	SELL	$39.61 - $42.76 $560,441 - $605,011	-14,149 Reduced 15.36%	77,975 $3.14 Million
Q1 2018 May 02, 2018	SELL	$36.18 - $40.15 $1.09 Million - $1.21 Million	-30,211 Reduced 24.7%	92,124 $3.6 Million
Q4 2017 Feb 09, 2018	SELL	$35.34 - $41.9 $214,231 - $253,997	-6,062 Reduced 4.72%	122,335 $4.34 Million
Q3 2017 Nov 03, 2017	BUY	$39.44 - $41.55 $1.15 Million - $1.21 Million	29,208 Added 29.45%	128,397 $5.21 Million
Q2 2017 Aug 11, 2017	BUY	N/A	99,189	99,189 $4.28 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account